Engineers Gate Manager’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Engineers Gate Manager’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,073	Closed	-$502K	–	2156
2023 Q2	$502K	Buy	+13,073	New	+$336K	0.02%	1032
2022 Q3	–	Sell	-37,470	Closed	-$655K	–	2202
2022 Q2	$655K	Buy	+37,470	New	+$588K	0.02%	965

Engineers Gate Manager's KDNY Position: Q3 2023 in Review

Engineers Gate Manager sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 13,073 shares — an estimated $502K sold.

Engineers Gate Manager first reported a position in KDNY in Q2 2022 and held it in 2 quarters. The position peaked at $655K in Q2 2022. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Engineers Gate Manager reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Engineers Gate Manager sold 13,073 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $502K.
Engineers Gate Manager first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Engineers Gate Manager's Chinook Therapeutics, Inc. Common Stock position peaked at $655K in Q2 2022.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Engineers Gate Manager's 13F filing for Q3 2023, filed 14 Nov 2023.